This announcement is a separate document:
关于江苏联环药业股份有限公司调整2019年限制性股票激励计划回购价格及终止实施2019年限制性股票激励计划并回购注销限制性股票之法律意见书
Legal Opinion on Jiangsu Lianhuan Pharmaceutical Co., Ltd.\'s adjustment of the repurchase price of the 2019 restricted stock incentive plan, termination of implementation of the 2019 restricted stock incentive plan, and repurchase and cancellation of rest
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated